NCT07218172View on ClinicalTrials.gov

Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B)

CompletedOBSERVATIONAL
Enrollment

197

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

April 24, 2025

Study Completion Date

April 24, 2025

Conditions
Severe Asthma
Trial Locations (1)

Unknown

Research Site, Tel Aviv

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY